Dr. Otegbeye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5000
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2010 - 2013
Harvard School of Public HealthMPH, 2008 - 2009
Obafemi Awolowo University, Ile-IfeClass of 2005
Certifications & Licensure
WA State Medical License 2021 - 2026
OH State Medical License 2013 - 2022- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT Start of enrollment: 2024 Jun 01
Publications & Presentations
PubMed
- 65 citationsMembrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells.Evelyn Ojo, Ashish Sharma, Ruifu Liu, Stephen Moreton, Mary Ann Checkley-Luttge
Scientific Reports. 2019-10-17 - 3 citationsA multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.Leland L Metheny, Ronald Sobecks, Christina Cho, Pingfu Fu, Seunghee Margevicius
Blood Advances. 2024-03-26 - 39 citationsMultiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.Michael Maschan, Paolo F Caimi, Jane Reese-Koc, Gabriela Pacheco Sanchez, Ashish A Sharma
Nature Communications. 2021-12-10
Grant Support
- Research Training Award for FellowsAmerican Society of Hematology2015–2016
Professional Memberships
- Member
- Member
- Member
- American Society for Blood and Marrow TransplantationMember
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
